Prevention of rheumatic heart disease in New Zealand: High-dose subcutaneous benzathine penicillin is cost-saving compared with traditional intramuscular injections.

Leung W, Baker MG, Manning L, Bennett J

Open source

DOI
10.1016/j.ijregi.2025.100784
Published
2025 Dec
Container
IJID regions
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijregi.2025.100784,
  title = {Prevention of rheumatic heart disease in New Zealand: High-dose subcutaneous benzathine penicillin is cost-saving compared with traditional intramuscular injections.},
  author = {Leung W and Baker MG and Manning L and Bennett J},
  year = {2025},
  journal = {IJID regions},
  doi = {10.1016/j.ijregi.2025.100784},
  url = {https://doi.org/10.1016/j.ijregi.2025.100784}
}

RIS

TY  - JOUR
TI  - Prevention of rheumatic heart disease in New Zealand: High-dose subcutaneous benzathine penicillin is cost-saving compared with traditional intramuscular injections.
AU  - Leung W
AU  - Baker MG
AU  - Manning L
AU  - Bennett J
PY  - 2025
JO  - IJID regions
DO  - 10.1016/j.ijregi.2025.100784
UR  - https://doi.org/10.1016/j.ijregi.2025.100784
ER  - 

APA

W, L., MG, B., L, M., & J, B. (2025). Prevention of rheumatic heart disease in New Zealand: High-dose subcutaneous benzathine penicillin is cost-saving compared with traditional intramuscular injections.. IJID regions. https://doi.org/10.1016/j.ijregi.2025.100784

Source records